Journal of Medical Economics, Volume 16, Issue 7 (2013)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 16, Issue 7 (2013)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Volume 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Review

Review Article
Is dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide
Louise Justesen Hesselbjerg, Heidi Sjoelund Pedersen, Mikael Bergholdt Asmussen & Karin Dam Petersen
Pages: 845-858
Published online: 15 May 2013
AbstractforIs dabigatran considered a cost-effective alternative to warfarin treatment: a review of current economic evaluations worldwide | Full Text | References | PDF (153.5 KB)
  • 631 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Original Articles

Article
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design
Mark Cascione, Daniel Wynn, Luigi M. Barbato, Linda Pestreich, Lesley Schofield & Kevin McCague
Pages: 859-865
Published online: 20 May 2013
AbstractforRandomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design | Full Text | References | PDF (159.3 KB)
  • 1256 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Understanding the effects on HR-QoL of treatment for overactive bladder: a detailed analysis of EQ-5D clinical trial data for mirabegron
M. Pavesi, N. Devlin, Z. Hakimi, J. Nazir, M. Herdman, C. Hoyle & I. A. Odeyemi
Pages: 866-876
Published online: 20 May 2013
AbstractforUnderstanding the effects on HR-QoL of treatment for overactive bladder: a detailed analysis of EQ-5D clinical trial data for mirabegron | Full Text | References | PDF (633 KB)
  • 499 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK
Anthony J. Batty, Ryan N. Hansen, Lisa M. Bloudek, Sepideh F. Varon, Esther J. Hayward, Becky W. Pennington, Richard B. Lipton & Sean D. Sullivan
Pages: 877-887
Published online: 22 May 2013
AbstractforThe cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK | Full Text | References | PDF (730.3 KB)
  • 2229 Views
  • 43 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost and utilization of healthcare services for hip and knee replacement
Chris M. Kozma, Terra Slaton, Andy Paris & Eric T. Edgell
Pages: 888-896
Published online: 23 May 2013
AbstractforCost and utilization of healthcare services for hip and knee replacement | Full Text | References | PDF (156.3 KB) | Supplemental
  • 1126 Views
  • 22 CrossRef citations
  • 0Altmetric
Free Access
Article
Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: A population-based Danish cohort study
Sigrun A. Johannesdottir, Christian F. Christiansen, Martin B. Johansen, Morten Olsen, Xiao Xu, Joseph M. Parker, Nestor A. Molfino, Timothy L. Lash & Jon P. Fryzek
Pages: 897-906
Published online: 23 May 2013
AbstractforHospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: A population-based Danish cohort study | Full Text | References | PDF (196.8 KB) | Supplemental
  • 1389 Views
  • 35 CrossRef citations
  • 0Altmetric
Free Access
Article
Budget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspective
C. Montouchet, L. Ruff & S. Balu
Pages: 907-916
Published online: 23 May 2013
AbstractforBudget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspective | Full Text | References | PDF (303.6 KB)
  • 474 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia
John M. Kane, Raymond Sanchez, Joan Zhao, Anna R. Duca, Brian R. Johnson, Robert D. McQuade, Anna Eramo, Ross A. Baker & Timothy Peters-Strickland
Pages: 917-925
Published online: 28 May 2013
AbstractforHospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia | Full Text | References | PDF (158 KB)
  • 2722 Views
  • 42 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m2 in Spain
Tiago Fonseca, John Clegg, Giuseppe Caputo, Kirsi Norrbacka, Tatiana Dilla & Maria Alvarez
Pages: 926-938
Published online: 31 May 2013
AbstractforThe cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m2 in Spain | Full Text | References | PDF (504.1 KB)
  • 1075 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access

Original Articles

Article
Treatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands
Korinna Karampampa, Anders Gustavsson, Erik Th. L. van Munster, Raymond M. M. Hupperts, Evert A. C. M. Sanders, Jop Mostert, Okke L. G. F. Sinnige, Jaap de Graaf, Paul Pop, Carolin Miltenburger, Martijn T. Groot, Milon Relleke & W. S. van der Hel
Pages: 939-950
Published online: 12 Jun 2013
AbstractforTreatment experience, burden, and unmet needs (TRIBUNE) in Multiple Sclerosis study: the costs and utilities of MS patients in The Netherlands | Full Text | References | PDF (215.8 KB)
  • 1443 Views
  • 33 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data
Krithika Rajagopalan, Mariam Hassan, Ken O’Day, Kellie Meyer & Fred Grossman
Pages: 951-961
Published online: 07 Jun 2013
AbstractforCost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data | Full Text | References | PDF (320 KB)
  • 1730 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Article
Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis
Juliana Setyawan, Paul Hodgkins, Annie Guérin, Geneviève Gauthier, Martin Cloutier, Eric Q. Wu & M. Haim Erder
Pages: 962-975
Published online: 07 Jun 2013
AbstractforComparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis | Full Text | References | PDF (698.4 KB) | Supplemental
  • 1268 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access
Article
Clinical and economic benefit of enzymatic debridement of pressure ulcers compared to autolytic debridement with a hydrogel dressing
Curtis Waycaster & Catherine T. Milne
Pages: 976-986
Published online: 07 Jun 2013
AbstractforClinical and economic benefit of enzymatic debridement of pressure ulcers compared to autolytic debridement with a hydrogel dressing | Full Text | References | PDF (960.7 KB)
  • 2796 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 30 Apr 2024
Open Access
Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-Cell lymphoma
Justin Gatwood et al.
Article | Published online: 30 Apr 2024
Open Access
A comparison of healthcare utilization and outcomes following skin vs. serum-specific IgE allergy testing
Yang Z. Lu et al.
Article | Published online: 29 Apr 2024
Open Access
Impact of Pseudomonas aeruginosa on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasis
Meg Franklin et al.
Article | Published online: 27 Apr 2024
Open Access
View all latest articles